Research suggests that blessed thistle (Cnicus benedictus) may possess anti-inflammatory properties, with a 2024 laboratory study finding that root extracts inhibited the enzyme 5-lipoxygenase, a mechanism relevant to inflammatory processes, and linked this activity to specific phenolic compounds including trans chalcone and 3-hydroxy flavone. The available evidence consists primarily of preclinical laboratory and animal studies, with no clinical trials in humans identified, which substantially limits conclusions about real-world efficacy. Two of the linked studies examine other thistle species entirely — milk thistle compounds silybin and silymarin, and the Mexican thistle Cirsium ehrenbergii — and while these point to anti-inflammatory activity within the broader thistle family, their findings cannot be directly applied to blessed thistle. Overall, the research base for blessed thistle specifically as an anti-inflammatory agent remains preliminary, and considerably more investigation, including human studies, would be needed before strong conclusions can be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| HPLC/ESI-MS Characterization of Phenolic Compounds from Cnicus benedictus L. ... | Other | 2024 | Supports | 72 |
| Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and crit... | Review | 2015 | Neutral | 67 |
| Five centuries of Cirsium ehrenbergii Sch. Bip. (Asteraceae) in Mexico, from ... | Other | 2023 | Neutral | 62 |
| Activation of Sirtuin 3 by Silybin Attenuates Mitochondrial Dysfunction in Ci... | Other | 2017 | Neutral | 57 |